162 related articles for article (PubMed ID: 32484118)
1. Prospective monitoring of carbapenem use and pseudomonal resistance across pediatric institutions.
Miyairi I; Shoji K; Kinoshita N; Saitoh J; Sugahara Y; Watanabe Y; Komura M; Kasai M; Horikoshi Y; Shinjoh M; Igarashi T;
Infect Control Hosp Epidemiol; 2020 Sep; 41(9):1042-1047. PubMed ID: 32484118
[TBL] [Abstract][Full Text] [Related]
2. A new carbapenem drug dosage metric for carbapenem usage and correlation with carbapenem resistance of Pseudomonas aeruginosa.
Hirayama S; Yasui K; Murakami H; Kosugi T; Sakamoto M; Hanai Y; Matsuo K; Miyazaki T; Ishii Y; Nishizawa K; Tateda K
J Infect Chemother; 2018 Dec; 24(12):949-953. PubMed ID: 30268412
[TBL] [Abstract][Full Text] [Related]
3. Imipenem, meropenem, or doripenem to treat patients with Pseudomonas aeruginosa ventilator-associated pneumonia.
Luyt CE; Aubry A; Lu Q; Micaelo M; Bréchot N; Brossier F; Brisson H; Rouby JJ; Trouillet JL; Combes A; Jarlier V; Chastre J
Antimicrob Agents Chemother; 2014; 58(3):1372-80. PubMed ID: 24342638
[TBL] [Abstract][Full Text] [Related]
4. Impact of carbapenem restriction on the antimicrobial susceptibility pattern of Pseudomonas aeruginosa isolates in the ICU.
Abdallah M; Badawi M; Amirah MF; Rasheed A; Mady AF; Alodat M; Alharthy A
J Antimicrob Chemother; 2017 Nov; 72(11):3187-3190. PubMed ID: 28961733
[TBL] [Abstract][Full Text] [Related]
5. When pharmacodynamics trump costs: an antimicrobial stewardship program's approach to selecting optimal antimicrobial agents.
Goff DA; Nicolau DP
Clin Ther; 2013 Jun; 35(6):766-71. PubMed ID: 23795574
[TBL] [Abstract][Full Text] [Related]
6. Pseudomonas aeruginosa carbapenem resistance mechanisms in Spain: impact on the activity of imipenem, meropenem and doripenem.
Riera E; Cabot G; Mulet X; García-Castillo M; del Campo R; Juan C; Cantón R; Oliver A
J Antimicrob Chemother; 2011 Sep; 66(9):2022-7. PubMed ID: 21653605
[TBL] [Abstract][Full Text] [Related]
7. Interpreting carbapenem susceptibility testing results for Pseudomonas aeruginosa.
Micaëlo M; Brossier F; Bréchot N; Luyt CE; Lu Q; Monsel A; Jarlier V; Aubry A
Med Mal Infect; 2018 Aug; 48(5):365-371. PubMed ID: 29628176
[TBL] [Abstract][Full Text] [Related]
8. Purchase of carbapenems in Vietnam, a low- to middle-income pharmaceutical market with a high burden of antimicrobial drug resistance.
Quynh NTN; Dat VQ
WHO South East Asia J Public Health; 2021; 10(1):12-17. PubMed ID: 35046152
[TBL] [Abstract][Full Text] [Related]
9. Correlation between meropenem and doripenem use density and the incidence of carbapenem-resistant Pseudomonas aeruginosa.
Shigemi A; Matsumoto K; Yaji K; Shimodozono Y; Takeda Y; Miyanohara H; Kawamura H; Orita M; Tokuda K; Nishi J; Yamada K
Int J Antimicrob Agents; 2009 Dec; 34(6):589-91. PubMed ID: 19748231
[TBL] [Abstract][Full Text] [Related]
10. Correlation between antimicrobial consumption and antimicrobial resistance of Pseudomonas aeruginosa in a hospital setting: a 10-year study.
Mladenovic-Antic S; Kocic B; Velickovic-Radovanovic R; Dinic M; Petrovic J; Randjelovic G; Mitic R
J Clin Pharm Ther; 2016 Oct; 41(5):532-7. PubMed ID: 27511808
[TBL] [Abstract][Full Text] [Related]
11. Pseudomonas aeruginosa is not just in the intensive care unit any more: implications for empirical therapy.
Eagye KJ; Banevicius MA; Nicolau DP
Crit Care Med; 2012 Apr; 40(4):1329-32. PubMed ID: 22425824
[TBL] [Abstract][Full Text] [Related]
12. Assessing the pharmacodynamic profile of intravenous antibiotics against prevalent Gram-negative organisms collected in Colombia.
Villegas MV; Briceno DF; Ruiz SJ; Furtado GH; Nicolau DP
Braz J Infect Dis; 2011; 15(5):413-9. PubMed ID: 22230846
[TBL] [Abstract][Full Text] [Related]
13. Nationwide surveillance of antimicrobial consumption and resistance to Pseudomonas aeruginosa isolates at 203 Japanese hospitals in 2010.
Muraki Y; Kitamura M; Maeda Y; Kitahara T; Mori T; Ikeue H; Tsugita M; Tadano K; Takada K; Akamatsu T; Yamada T; Yamada T; Shiraishi T; Okuda M
Infection; 2013 Apr; 41(2):415-23. PubMed ID: 23471823
[TBL] [Abstract][Full Text] [Related]
14. Relationship between the usage of carbapenem antibiotics and the incidence of imipenem-resistant Pseudomonas aeruginosa.
Fujimura S; Nakano Y; Sato T; Shirahata K; Watanabe A
J Infect Chemother; 2007 Jun; 13(3):147-50. PubMed ID: 17593500
[TBL] [Abstract][Full Text] [Related]
15. The risk of seizures among the carbapenems: a meta-analysis.
Cannon JP; Lee TA; Clark NM; Setlak P; Grim SA
J Antimicrob Chemother; 2014 Aug; 69(8):2043-55. PubMed ID: 24744302
[TBL] [Abstract][Full Text] [Related]
16. Comparative Activity of Carbapenem Testing (COMPACT) study in Germany.
Valenza G; Seifert H; Decker-Burgard S; Laeuffer J; Morrissey I; Mutters R;
Int J Antimicrob Agents; 2012 Mar; 39(3):255-8. PubMed ID: 22230334
[TBL] [Abstract][Full Text] [Related]
17. Hand hygiene, and not ertapenem use, contributed to reduction of carbapenem-resistant Pseudomonas aeruginosa rates.
Pires dos Santos R; Jacoby T; Pires Machado D; Lisboa T; Gastal SL; Nagel FM; Kuplich NM; Konkewicz L; Gorniak Lovatto C; Pires MR; Goldani LZ
Infect Control Hosp Epidemiol; 2011 Jun; 32(6):584-90. PubMed ID: 21558771
[TBL] [Abstract][Full Text] [Related]
18. Carbapenem stewardship: does ertapenem affect Pseudomonas susceptibility to other carbapenems? A review of the evidence.
Nicolau DP; Carmeli Y; Crank CW; Goff DA; Graber CJ; Lima AL; Goldstein EJ
Int J Antimicrob Agents; 2012 Jan; 39(1):11-5. PubMed ID: 22047702
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of a carbapenem antimicrobial stewardship program and clinical outcomes in a Japanese hospital.
Komatsu T; Inagaki R; Azuma S; Mochida S; Sato Y; Seto Y; Nihonyanagi S; Hoshiyama T; Wada T; Takayama Y; Atsuda K
J Infect Chemother; 2022 Jul; 28(7):884-889. PubMed ID: 35331613
[TBL] [Abstract][Full Text] [Related]
20. Correlation between the consumption of meropenem or doripenem and meropenem susceptibility of Pseudomonas aeruginosa in a university hospital in Japan.
Miyawaki K; Miwa Y; Seki M; Asari S; Tomono K; Kurokawa N
Biol Pharm Bull; 2012; 35(6):946-9. PubMed ID: 22687536
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
